Evidence map›Paper›PMID 25361623›Full record

ArticleThe oncologist2015

What keeps oncologists from addressing palliative care early on with incurable cancer patients? An active stance seems key.

Timo A Pfeil, Katsiaryna Laryionava, Stella Reiter-Theil, Wolfgang Hiddemann, Eva C Winkler

Abstract read
In one paragraph

Article in The oncologist, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Association between the timing of palliative care consultation and end-of-life outcomes in patients with cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  5. Article
  6. Neuro-oncology practice · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Contribution of collegial support meetings (CSM) in the management of complex situations of patients with advanced cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Timo A PfeilDepartment of Internal Medicine III (Hematology and Oncology), University Hospital Grosshadern, Munich, Germany; Department of Medical Oncology, Program for Ethics and Patient-Oriented Care in Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany; Clinical Ethics, University Hospital Basel, Psychiatric Hospitals of the University Basel, Basel, Switzerland.
Katsiaryna LaryionavaDepartment of Internal Medicine III (Hematology and Oncology), University Hospital Grosshadern, Munich, Germany; Department of Medical Oncology, Program for Ethics and Patient-Oriented Care in Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany; Clinical Ethics, University Hospital Basel, Psychiatric Hospitals of the University Basel, Basel, Switzerland.
Stella Reiter-TheilDepartment of Internal Medicine III (Hematology and Oncology), University Hospital Grosshadern, Munich, Germany; Department of Medical Oncology, Program for Ethics and Patient-Oriented Care in Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany; Clinical Ethics, University Hospital Basel, Psychiatric Hospitals of the University Basel, Basel, Switzerland.
Wolfgang HiddemannDepartment of Internal Medicine III (Hematology and Oncology), University Hospital Grosshadern, Munich, Germany; Department of Medical Oncology, Program for Ethics and Patient-Oriented Care in Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany; Clinical Ethics, University Hospital Basel, Psychiatric Hospitals of the University Basel, Basel, Switzerland.
Eva C WinklerDepartment of Internal Medicine III (Hematology and Oncology), University Hospital Grosshadern, Munich, Germany; Department of Medical Oncology, Program for Ethics and Patient-Oriented Care in Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany; Clinical Ethics, University Hospital Basel, Psychiatric Hospitals of the University Basel, Basel, Switzerland Eva.Winkler@med.uni-heidelberg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSympathetic and frank communication about the terminal nature of advanced cancer is important to improve patients' prognostic understanding and, thereby, to allow for adjustment of treatment intensity to realistic goals; however, decisions against aggressive treatments are often made only when death is imminent. This qualitative study explores the factors that hinder such communication and reconstructs how physicians and nurses in oncology perceive their roles in preparing patients for end-of-life (EOL) decisions.

methodsQualitative in-depth interviews were conducted with physicians (n = 12) and nurses (n = 6) working at the Department of Hematology/Oncology at the university hospital in Munich, Germany. The data were analyzed using grounded theory methodology and discussed from a medical ethics perspective.

resultsOncologists reported patients with unrealistic expectations to be a challenge for EOL communication that is especially prominent in comprehensive cancer centers. Oncologists responded to this challenge quite differently by either proactively trying to facilitate advanced care planning or passively leaving the initiative to address preferences for care at the EOL to the patient. A major impediment to the proactive approach was uncertainty about the right timing for EOL discussions and about the balancing the medical evidence against the physician's own subjective emotional involvement and the patient's wishes.

conclusionThese findings provide explanations of why EOL communication is often started rather late with cancer patients. For ethical reasons, a proactive stance should be promoted, and oncologists should take on the task of preparing patients for their last phase of life. To do this, more concrete guidance on when to initiate EOL communication is necessary to improve the quality of decision making for advanced cancer patients.

Indexed as

Attitude of Health PersonnelEthics, MedicalGermanyHumansNeoplasmsPalliative CarePhysician-Patient RelationsPhysiciansTerminal CareCommunicationEnd-of-life decisionsMedical ethicsMedical oncologyPalliative care

Identifiers

PMID25361623
PMCPMC4294613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.